Mandeg, Luisa D.
HRN: 14-85-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2025
CEFTRIAXONE 1G (VIAL)
09/04/2025
09/06/2025
IV
2g
OD
S/p Evacuation Curettage
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines